The use of an insuflon device for the administration of G-CSF in pediatric cancer patients

M. E.A. De Jong; T. Carbière; M. M. Van Den Heuvel-Eibrink

doi:10.1007/s00520-005-0872-x

The use of an insuflon device for the administration of G-CSF in pediatric cancer patients

M. E.A. De Jong, T. Carbière, M. M. Van Den Heuvel-Eibrink

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.

Original language	English
Pages (from-to)	98-100
Number of pages	3
Journal	Supportive Care in Cancer
Volume	14
Issue number	1
DOIs	https://doi.org/10.1007/s00520-005-0872-x
Publication status	Published - Jan 2006
Externally published	Yes

Keywords

Granulocyte colony-stimulating factor
Insuflon device
Pediatric cancer

Access to Document

10.1007/s00520-005-0872-x

Cite this

@article{6d271da96b9747a4b4f230bf517f9186,

title = "The use of an insuflon device for the administration of G-CSF in pediatric cancer patients",

abstract = "In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.",

keywords = "Granulocyte colony-stimulating factor, Insuflon device, Pediatric cancer",

author = "\{De Jong\}, \{M. E.A.\} and T. Carbi{\`e}re and \{Van Den Heuvel-Eibrink\}, \{M. M.\}",

year = "2006",

month = jan,

doi = "10.1007/s00520-005-0872-x",

language = "English",

volume = "14",

pages = "98--100",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - The use of an insuflon device for the administration of G-CSF in pediatric cancer patients

AU - De Jong, M. E.A.

AU - Carbière, T.

AU - Van Den Heuvel-Eibrink, M. M.

PY - 2006/1

Y1 - 2006/1

N2 - In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.

AB - In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.

KW - Granulocyte colony-stimulating factor

KW - Insuflon device

KW - Pediatric cancer

UR - https://www.scopus.com/pages/publications/31044434625

U2 - 10.1007/s00520-005-0872-x

DO - 10.1007/s00520-005-0872-x

M3 - Article

C2 - 16096770

AN - SCOPUS:31044434625

SN - 0941-4355

VL - 14

SP - 98

EP - 100

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 1

ER -

The use of an insuflon device for the administration of G-CSF in pediatric cancer patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this